KIDRON NADAV 4
4 · ORAMED PHARMACEUTICALS INC. · Filed May 31, 2023
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-05-26+120,000→ 1,452,098 total
Holdings
- 126,000(indirect: By wholly-owned corporation)
Common Stock
Footnotes (1)
- [F1]Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.